https://www.selleckchem.com/pr....oducts/bay-11-7085.h
fine-tuning the immunomodulation of hMSCs with different clinical implications in hMSCs therapy. The present study uncovers a novel function of DLC-1 tumor suppressor in regulating the immunomodulation of hMSCs. It also proposes a novel mutual exclusion mechanism between the DLC-1 signaling and the Notch1 signaling that is possibly responsible for fine-tuning the immunomodulation of hMSCs with different clinical implications in hMSCs therapy. Rapid weight gain (RWG) during infancy increases the risk of excess weight later in life. N
Curtir
Comentario
Compartilhar
